Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth of 16%. Consolidated Net Profit of ₹1,984 Crore, up 187% from -(₹2,227) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.3, up 187% from -(₹9.49) in the same quarter of the previous year.
